Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
KYKOF
Stock Latest News
Company Announcements
Kyowa Kirin’s Poteligeo Study: A Closer Look at Safety and Efficacy
8d ago
KYKOF
Premium
Company Announcements
Kyowa Kirin Earnings Call: Mixed Sentiment Amid Growth and Challenges
23d ago
Premium
Company Announcements
Kyowa Kirin’s Promising Phase 2 Study on DME Treatment: A Market Game-Changer?
29d ago
KYKOF
Premium
Company Announcements
Kyowa Kirin’s KHK4827 Study Completion: A Potential Game-Changer for Systemic Sclerosis Treatment
2M ago
KYKOF
Premium
Company Announcements
Kyowa Kirin’s Phase 3 Study on KHK4827 for Systemic Sclerosis: Market Implications
2M ago
KYKOF
Premium
Company Announcements
Kyowa Kirin’s Promising Study on KHK4951 for Diabetic Macular Edema: A Potential Game-Changer
2M ago
KYKOF
Premium
The Fly
Kura, Kyowa say ziftomenib abstract accepted for EHA Congress
4M ago
KURA
Premium
Pre-Earnings
Is KYKOF a Buy, Before Earnings?
7M ago
Premium
The Fly
Nvidia reports Q3 beat, Starbucks explores China partnerships: Morning Buzz
9M ago
BA
BJ
Premium
The Fly
Kura Oncology price target lowered to $18 from $22 at Scotiabank
9M ago
KURA
SNDX
Premium
Market News
A Promising Pipeline Ready to Break out at BridgeBio Pharma (BBIO)
12M ago
BBIO
Premium
Market News
Ardelyx (ARDX) Beats Expectations in Q2 and Offers Promising Outlook
12M ago
ARDX
Premium
Company Announcements
Kyowa Kirin Advances Share Buyback Program
1y ago
Premium
Company Announcements
Kyowa Kirin Restructures APAC Operations and Licensing
1y ago
Premium
The Fly
Orchard Therapeutics announces multiple presentations at ASGCT 2024
1y ago
Premium
The Fly
Orchard Therapeutics outlines U.S. launch plans for Lenmeldy
1y ago
Premium
The Fly
Kyowa Kirin to present Phase 2b post-hoc analysis on rocatinlimab
1y ago
Premium
The Fly
Kyowa Kirin reinstated with a Neutral at Goldman Sachs
1y ago
Premium
The Fly
BridgeBio, Kyowa Kirin announces partnership
2y ago
BBIO
Premium
The Fly
Orchard Therapeutics announces first patient randomized in trial of OTL-203
2y ago
Premium
The Fly
Ardelyx to present updates for XPHOZAH at Kidney Week 2023
2y ago
ARDX
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
